References
- DickersonLMMazyckPJHunterMHPremenstrual syndromeAm Fam Physician20036781743175212725453
- Rendas-BaumRYangMGricarJWallensteinGVCost-effectiveness analysis of treatments for premenstrual dysphoric disorderAppl Health Econ Health Policy20108212914020175591
- FrackiewiczEJShiovitzTMEvaluation and management of premenstrual syndrome and premenstrual dysphoric disorderJ Am Pharm Assoc (Wash)200141343744711372908
- CocoASPrimary dysmenorrheaAm Fam Physician199960248949610465224
- ToniniGDysmenorrhea, endometriosis and premenstrual syndromeMinerva Pediatr200254652553812388941
- YonkersKAO’BrienPMPremenstrual syndromeLancet200837196191200121018395582
- LefebvreGPinsonneaultOAntaoVPrimary dysmenorrhea consensus guidelineJ Obstet Gynaecol Can20052716911191120
- FariedAKurniaDFariedLSAnticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell linesInt J Oncol200730360561317273761
- TjandrawinataRRArifinPFTandrasasmitaOMRahmiDAripinADLBS1425, a Phaleria macrocarpa (Scheff.) Boerl. extract confers anti-proliferative and pro-apoptosis effects via eicosanoid pathwayJ Exp Ther Oncol20108318720120734918
- IndoherbalfarmaCrown god, Phaleria macrocarpa, as medicine Available at: http://indoherbalfarma.co.cc/crown-god-phaleria-macrocarpa-as-medicine.html. Accessed June 25, 2010.
- ArifinPFAripinAATjandrawinataRRDLBS1442: A Phaleria macrocarpa (Scheff.) Boerl. extract which confers anti-inflammatory effectMedicinusIn press;2011
- World Medical Association Declaration of HelsinkiRecommendations guiding physicians in biomedical research involving human patientsAmended by the 52nd WMA General AssemblyEdinburgh, ScotlandOctober 2000 Available from: http://www.flebologia.unisi.it/lineeguida/declarationingl.htm. Accessed May 14, 2011.
- International Conference on Harmonisation (ICH) Topic E 6Harmonised Tripartite Guideline for Good Clinical PracticeStep5 Consolidated Guideline 1 May 1996. Available from: http://www.hc-sc.gc.ca/dhp-mps/prodpharma/applic-demande/guide-ld/ich/efficac/e6-eng.php. Accessed May 14, 2011.
- CasperRFPowellAMPremenstrual syndrome: Documentation by a linear analog scale compared with two descriptive scalesAm J Obstet Gynecol198615548628673766642
- TandrasasmitaOMLeeJSBaekSHTjandrawinataRRInduction of cellular apoptosis in human breast cancer by DLBS1425, a Phaleria macrocarpa compound extract, via downregulation of PI3-kinase/AKT pathwayCancer Biol Ther201010881482320703095
- ToddKHClinical versus statistical significance in the assessment of pain reliefAnn Emerg Med19962744394418604855
- KellyAMDoes the clinically significant difference in VAS pain score differ with age, gender or cause of pain?Acad Emerg Med1998511108610909835471
- KellyAMThe minimum clinically significant difference in visual analogue scale pain score does not differ with severity of painEmerg Med J200118320520711354213
- MolineMLZendellSMEvaluating and managing premenstrual syndromeMedscape Womens Health20005211610792850
- CalhounAHHutchinsonSHormonal therapies for menstrual migraineCurr Pain Headache Rep200913538138519728965
- ArifinPFTjandrawinataRRRole of DLBS1442 in decreasing the expression of estrogen receptor-alphaMedicinusIn press;2011
- HendeyGWDonnerNFFullerKClinically significant changes in nausea as measured on a visual analog scaleAnn Emerg Med2005451778115635314